immatics biotechnologies GmbH
Patents, Design & Utilities

Last updated:

List of all immatics biotechnologies GmbH patents 820 in total

Status Patent
Grant
Utility: Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 20 Aug 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2019
Grant
Utility: Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2019
Grant
Utility: Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2019
Grant
Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 8 Aug 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 8 Aug 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 8 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 8 Sep 2025 Issue date: 6 Aug 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 1 Aug 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 1 Aug 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 30 Jul 2019
Grant
Utility: Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers External link
Filling date: 8 Sep 2025 Issue date: 30 Jul 2019
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against NHL and other cancers External link
Filling date: 8 Sep 2025 Issue date: 30 Jul 2019
Grant
Utility: Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) External link
Filling date: 8 Sep 2025 Issue date: 30 Jul 2019
Grant
Utility: Immunotherapy against melanoma and other cancers External link
Filling date: 8 Sep 2025 Issue date: 30 Jul 2019

Showing 800 to 820 of 820 patents.